This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Geir Åge Løset, PhD
CEO at Nextera AS


Co-founder and Chief Executive Officer at Nextera AS

Dr. Geir Åge Løset has more than 20 years of academic and industrial experience within the biotechnology sector where his work has focused primarily on antibody, T cell receptor and MHC engineering by use of phage display. Dr. Løset earned his PhD at the University of Oslo and spent parts of his post-doctoral training at the CSIRO Molecular and Health Technologies in Melbourne, Australia.

Dr. Løset is Chief Executive Officer and co-founder of Nextera AS. He is an associate member of the K.G. Jebsen Coeliac Disease Research Centre and an Associate Professor at the Department of Biosciences, University of Oslo.

Agenda Sessions

  • LIVE Moderated Panel Discussion and Q&A Including Audience Interaction with Speakers from On-Demand SESSION #1: FINDING THE RIGHT ANTIBODY - To prepare for this discussion/Q&A, attendees should view the presentations from Session #1 in the Watch On-Demand Sessions Tab prior to this session

  • Phage Display Selection of TCR-like antibodies

    On Demand